[1]
Zhou, Y., Chen, Y., Ma, C., Shao, B. and Zhang, F. 2020. Liposomal clodronate combined with Cisplatin or Sorafenib inhibits hepatocellular carcinoma cell proliferation, migration and invasion by suppressing FOXQ1 expression. Cellular and Molecular Biology. 66, 1 (Apr. 2020), 49–54. DOI:https://doi.org/10.14715/cmb/2019.66.1.8.